|
Market Closed -
Nasdaq
16:00:00 2026-09-29 EDT
|
5-day change | 1st Jan Change | ||
| 16.35 USD | +0.18% |
|
+0.74% | +105.53% |
| 08-24 | Personalis Shares Fall After Craig-Hallum Downgrade | MT |
| 08-24 | Craig-Hallum Downgrades Personalis to Hold From Buy, Price Target is $16.25 | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Other Biotechnology & Medical Research
| Capi. | Sales Growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 1.74B | - | ||||
| 49.06B | |||||
| 44.6B | |||||
| 43.24B | - | - | - | - | - |
| 41.73B | |||||
| 29.93B |
- Stock Market
- Stocks
- PSNL Stock
- Charts Personalis, Inc.
- Sector Chart
Select your edition
All financial news and data tailored to specific country editions
